Neoadjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer
Neoadjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer
Active, not recruiting · NCT04126525 · Registry updated 2025-09-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neoadjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer | Breast Cancer Female | Active, not recruiting | Phase 2 | 2025-09-11 | NCT04126525 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| RenJi Hospital | 264 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Renji Hospital | Shanghai | China | 12 |